In addition to the age of diagnosis, FIGO stage, degree of differentiation, depth of myometrial invasion, lymph node metastasis and PR and ER status, high expression of TMEFF1 also affected the overall survival of patients with endometrial carcinoma and was an independent risk factor for prognosis. This evidence concerns the gene TMEFF1 and metastatic malignant neoplasm in the lymph nodes.